Hipra, a veterinary pharmaceutical company with subsidiaries in 19 countries, has opened in the UK and launched Eficur (ceftiofur hydrochloride).

Eficur is a ready to use injectable suspension for the treatment of bacterial respiratory disease associated with Mannheimia haemolytica, Pasteurella multocida and Histhophillus Somni in cattle and additionally Actinobacillus pleuropneumonia, Streptococcus suis and others in swine.

Eficur is also licensed for the treatment of acute interdigital necrobacillosis (panaritium, foot rot) and the bacterial component of acute post-partum (puerperal) metritis in cattle.

Eficur is available in a presentation of 50 ml, 100 ml and 250 ml. The 250 ml presentation also includes an innovative unbreakable protector.

For further information please contact: Hipra UK on 0115 812 0499 or uk@hipra.com, or visit www.hipra.com

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.